ARCHIVES

Wyden Asks Bristol For documentation To Prove That Taxol Price Is Not “Gouging” Taxpayers

This article is from The Cancer Letter archive.

Vol. 19 No. 05 | January 29, 1993

Download PDF Visit The Full Archive

Related Articles

States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp

November 6, 2009

Blazing the Pathways: Informatics Platform Provides Foundation for “Center Without Walls”

January 11, 2013

Elevated Baseline Glucose Levels Associated With Higher Cancer Risk

November 25, 2011

Abbott To Supply Quest With Immunoassay Tests.

September 29, 2000

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

October 19, 2007

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010